University of Hong Kong’s new liver cancer treatment strategy gives patients hope with increase in 2-year survival rate

• New approach combines three common liver cancer treatments, says Clinical Professor Albert Chan
• Half of 33 patients saw tumours shrink, allowing them to be removed, study finds